Fexoform AM Tablet combines Montelukast (10mg), Fexofenadine (120mg), and Acebrophylline (200mg) in a Sustained Release formula, designed to provide effective relief from a range of respiratory and allergic conditions. This combination therapy is specifically formulated for individuals suffering from chronic allergic rhinitis, seasonal allergies, asthma, and other respiratory issues.
Montelukast, a leukotriene receptor antagonist, helps reduce inflammation in the airways, preventing asthma attacks and managing allergy symptoms such as sneezing, runny nose, and itchy eyes. Fexofenadine, a second-generation antihistamine, alleviates allergic symptoms like itching, sneezing, and hives by blocking histamine receptors. Acebrophylline, a bronchodilator and mucolytic, improves airflow by relaxing the muscles around the airways and thinning mucus, making it easier to breathe.
This combination of medications works synergistically to provide comprehensive management of both allergic reactions and respiratory distress, offering sustained relief throughout the day.